Late cycle. Medicine ++

190
In November 2023, it was reported that German chemical concern Bayer AG was considering options for splitting the business due to weak financial performance.

Management considered several options:

spinning off the health products or agricultural fertilizer businesses into a separate company;
maintaining a three-division structure but getting rid of non-core assets;
successive splits into three independent companies, each retaining its own divisions.

In January 2024, it was reported that Bayer announced a business restructuring and job cuts. The plan was to simplify the management model, eliminate bureaucracy and speed up decision-making processes. The job cuts were expected to begin in the coming months and should be completed by the end of 2025.

This company could go the same way as deutsche bank.

Get up off your knees and grow a few times over. =)

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.